General Medicare and Medicaid Issues.
2025 · 2nd Quarter (Apr 1 - June 30)
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
Filed by LMH STRATEGIC SOLUTIONS.
Open official filingSource-reported fields
Filing overview
- Type
- 2nd Quarter - Report
- Posted
- Jul 16, 2025
- Income
- $30,000.00
- Expenses
- Not reported
- Registrant
- LMH STRATEGIC SOLUTIONS
- Filing UUID
- ae4bce7d-6c4f-4104-880f-2cecd8f7543e
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Pharmaceutical Supply Chain. H.R.2213 - Medical Supply Chain Resiliency Act. Issues related to the 340(b) program. H.R.1492/S.832 - EPIC Act of 2025.
Literal federal measure citations: H.R.2213, H.R.1492, S.832
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.